|
How Does It
Work?:
Esberitox is a unique blend of wild indigo
root, coneflower root, and white cedar leaf that has been widely used in Europe
for decades. This powerful combination of herbs fortifies the immune system,
helping to strengthen the body's natural defense mechanisms.
Research has shown that the Esberitox
combination provides a broader range of activity than any individual component
alone. This additive effect is produced via the actions and interactions of the
concentrated botanical extracts. Although the activity of the individual
components overlap in some way, each herb is unique in how it enhances immune
function.
The following table summarizes the key benefits
of each ingredient:
| Ingredient |
Benefits |
| Echinacea purpurea and pallida |
Increase interferon production†
Stimulates B-cell and antibody production†
Increases interleukin-1 production†
Increases production of tumor necrosis
factor†
|
| Wild indigo (Baptisia
tinctoria |
Increases interferon production†
Stimulates B-cell and antibody production†
Increases interleukin-1 production†
|
| Thuja occidentalis
(white cedar leaf) |
Enhances T-4 helper cells and increases
interleukin-2 production†
|
| Esberitox® |
Increases chemotaxis of white blood cells†
Increases phagocytosis rate and killing
capacity of neutrophils†
Activates macrophages†
Increases phagocytosis of macrophages†
|
Clinical Research Findings
The safe and efficacious use of Esberitox in both children and adults has
been documented in over thirty clinical and scientific studies. Unlike
Echinacea, which has generated both negative and positive results, studies on
the Esberitox combination have yielded only positive findings.
Immune System Support
Several studies have examined the ability of Esberitox to quickly
and effectively enhance immune system function. The powerful combination
promotes the body's resistive functions by stimulating the production and
activity of critical immune cells.
One randomized, double-blind, placebo
controlled, multi-center study involving 263 adults, found that improvement was
noticeable after only two days of supplementation - three days earlier than the
placebo group. Similar benefits have been noted in children, where safety and
tolerability have been established for those as young as two years of age.
Esberitox is
especially beneficial when extra immune system support is desired.† Clinical
research has demonstrated that supplementation increased the rate of
phagocytosis by 7.4%, whereas the rate in the placebo group decreased 3.2%.
Phagocytosis is a process through which immune cells rid the body of waste and
foreign bodies. Esberitox has also been shown to double the level of
killer cell activity and the lymphocyte count in individuals in need of immune
support.* These findings provide strong evidence of Esberitox's ability to
stimulate the immune system.
|
Description